Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Cavo M;Gay F;Beksac M;Pantani L;Petrucci MT;Dimopoulos MA;Dozza L;van der Holt B;Zweegman S;Oliva S;van der Velden VHJ;Zamagni E;Palumbo GA;Patriarca F;Montefusco V;Galli M;Maisnar V;Gamberi B;Hansson M;Belotti A;Pour L;Ypma P;Grasso M;Croockewit A;Ballanti S;Offidani M;Vincelli ID;Zambello R;Liberati AM;Andersen NF;Broijl A;Troia R;Pascarella A;Benevolo G;Levin MD;Bos G;Ludwig H;Aquino S;Morelli AM;Wu KL;Boersma R;Hajek R;Durian M;von dem Borne PA;Caravita di Toritto T;Zander T;Driessen C;Specchia G;Waage A;Gimsing P;Mellqvist UH;van Marwijk Kooy M;Minnema M;Mandigers C;Cafro AM;Palmas A;Carvalho S;Spencer A;Boccadoro M;Sonneveld P;;
The Lancet. Haematology 2020 Vol. 7 pp. -
310
m2020theautologous

Abstract

Janssen and Celgene.

Citation

ID: 274192
Ref Key: m2020theautologous
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
274192
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet